Anna Schwendeman

University of Michigan–Ann Arbor — United States

Medicine · Health Sciences

40h-index7.9kcitations304works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(139), Cancer, Hypoxia, and Metabolism(112), ATP Synthase and ATPases Research(81), Epigenetics and DNA Methylation(22), Cholesterol and Lipid Metabolism(22)

Publications303 total

ApoE-Dependent Lipid Handling by Median Eminence Microglia Preserves Myelin Integrity and Metabolic Function
2026Open Access
Abstract PR003: KLIPP: Targeting fusion oncogenes with CRISPR
Cancer Research·2026
HDL in Abdominal Aortic Aneurysm: Mechanistic Insight and Therapeutic Potential
Current Atherosclerosis Reports·2026Open Access
Bilayer gelatin-methacryloyl scaffold for pulp inflammation suppression and dentin-like tissue regeneration
Journal of Controlled Release·2025
Supplementary Table S1 from Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance
2025Open Access
Supplementary Methods S1 from Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance
2025Open Access
Supplementary Figures S1-S17 from Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance
2025Open Access
Supplementary Table S2 from Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance
2025Open Access
Multimodal mass spectrometric characterization of structural microheterogeneity in rituximab reference and biosimilars
International Journal of Biological Macromolecules·2025Open Access
Reprogramming the Immune Suppressive Tumor Microenvironment in Glioma Enhances the Efficacy of Immune-Mediated Gene Therapy
2025
Reprogramming tumor microenvironment via systemic delivery of TLR3 agonist and manganese nanoparticle
Proceedings of the National Academy of Sciences·2025· 1 citedOpen Access
Tolerogenic nanodisc vaccination for the treatment of experimental autoimmune encephalomyelitis 2747
The Journal of Immunology·2025Open Access
947 PTEN modulation via trastuzumab-conjugated lipid nanoparticles enhances the efficacy of targeted immunotherapy in HER2-positive cancers
Regular and Young Investigator Award Abstracts·2025Open Access
Remote loading of an autoantigen in PLGA nanoparticles for the treatment of multiple sclerosis
Journal of Controlled Release·2025Open Access
Characterization of Crinone®: progesterone vaginal gel
International Journal of Pharmaceutics·2025Open Access
Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models
Circulation·2025· 3 citedOpen Access
In vitro release method development for Onivyde® using Agilent NanoDis® system
International Journal of Pharmaceutics·2025· 1 cited
A Comparative Study on Physicochemical and Analytical Characterizations of Doxil® and its Generic Drug Products
The AAPS Journal·2025· 4 citedOpen Access
Abstract 6371: KLIPP: Precision targeting of fusions and amplified oncogenes using CRISPR
Cancer Research·2025
HDL Nanodiscs Loaded with Liver X Receptor Agonist Decreases Tumor Burden and Mediates Long‐term Survival in Mouse Glioma Model
Small·2025· 4 citedOpen Access
page 1 of 16Next →

Frequent Co-authors

James J. Moon(20), Rui Kuai(15), Wenmin Yuan(15), Minzhi Yu(9), Emily E. Morin(8), Rose Ackermann(8), María G. Castro(7), Steven P. Schwendeman(7), Pedro R. Löwenstein(6), Jie Tang(6), Yao Xu(5), Lindsay Scheetz(5), Jutaek Nam(4), Padma Kadiyala(4), Alireza Hassani Najafabadi(4), Yayuan Liu(4), Ling Mei(4), Yanhong Guo(4), Lukasz J. Ochyl(3), Sejin Son(3)